癌治療についての4-ピリジルメチルフタラジンの使用

Title:

癌治療についての4-ピリジルメチルフタラジンの使用

Document Type and Number:

Japanese Patent JP2005502690

Kind Code:

A

Abstract:

Patients suffering from renal carcinoma are treated with a 4-pyridylmethyl-phthalazine anti-angiogenesis agent. Patients having different tumor types, e.g. renal cancer, are treated with a 4-pyridylmethyl-phthalazine anti-angiogenesis agent while undergoing chemotherapy.

More Like This:

JP2010520235	Direct use of non-toxic cross-linking reagents to resist progressive spinal cord alteration and deformity
JP2017095421	ANTIBACTERIAL AGENT
JP2021532106	Compositions Containing Bacterial Mini Cells and Methods of Use

Inventors:

Margaret Han Doogan
Janet Marjorie Wood

Application Number:

JP2003526411A

Publication Date:

January 27, 2005

Filing Date:

September 11, 2002

Export Citation:

Click for automatic bibliography generation Help

Assignee:

NOVARTIS AG

International Classes:

A61K45/00; A61K31/282; A61K31/50; A61K31/502; A61K31/513; A61K31/525; A61K31/663; A61K31/683; A61K31/7068; A61K33/243; A61K39/395; A61K45/06; A61P35/00; A61P35/04; (IPC1-7): A61K31/502; A61K31/282; A61K31/513; A61K31/525; A61K31/663; A61K31/683; A61K31/7068; A61K33/24; A61K39/395; A61K45/00; A61P35/00; A61P35/04

Attorney, Agent or Firm:

Aoyama Aoi
Mitsutaka Iwasaki
Shoji Nakajima
Kazuaki Kojima

Previous Patent: エナラプリルエステルの経皮投与

Next Patent: 精製ヘプタフルオロプロパンを得る方法